MGRX - Latest News

Mangoceuticals, Inc. (MGRX), operates in Healthcare / Medical - Healthcare Information Services, trades on NASDAQ.

Market capitalization stands near $6.3M. Beta to the broader market is 1.98.

The article list below shows the most recent MGRX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MGRX Headlines

Mangoceuticals (NASDAQ: MGRX) closes 74% premium stock sale with warrants

defenseworld.net - Oct 11, 2026

What happened Mangoceuticals, Inc. (NASDAQ: MGRX) closed a registered direct offering on October 9, 2026 for about $492,750.

Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close

globenewswire.com - Oct 9, 2026

Transaction follows a $2. 5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS,

Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session

benzinga.com - Oct 2, 2026

U. S.

Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche

globenewswire.com - Oct 1, 2026

Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance

Head to Head Survey: Mangoceuticals (NASDAQ:MGRX) and Chemed (NYSE:CHE)

defenseworld.net - Sep 21, 2026

Chemed (NYSE: CHE - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the superior inve

How News Affects MGRX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MGRX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MGRX news questions

What is the latest MGRX news headline?

The most recent MGRX headline (Oct 11, 2026) is "Mangoceuticals (NASDAQ: MGRX) closes 74% premium stock sale with warrants". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MGRX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MGRX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MGRX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.